ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

ClinicalTrials.gov ID: NCT00849147

Public ClinicalTrials.gov record NCT00849147. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 2:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Phase II Trial of Nonmyeloablative Conditioning (NST) and Transplantation of Partially HLA-Mismatched Bone Marrow From Related Donors for Patients With Hematologic Malignancies (BMT CTN #0603)

Study identification

NCT ID
NCT00849147
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Medical College of Wisconsin
Other
Enrollment
55 participants

Conditions and interventions

Interventions

  • GVHD prophylaxis Biological
  • Haploidentical Bone Marrow Transplantation Biological

Biological

Eligibility (public fields only)

Age range
1 Year to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2008
Primary completion
May 31, 2011
Completion
Oct 31, 2013
Last update posted
Jan 3, 2023

2008 – 2013

United States locations

U.S. sites
17
U.S. states
14
U.S. cities
16
Facility City State ZIP Site status
City of Hope National Medical Center Duarte California 91010-3000
University of California San Diego Medical Center La Jolla California 92093
University of Florida College of Medicine (Shands) Gainesville Florida 32610-0277
Bone Marrow Transplant Group of Georgia, Northside Hospital Atlanta Georgia 30342
Kapi'olani Medical Center for Women and Children, University of Hawaii Honolulu Hawaii 96826
University of Maryland, Greenbaum Cancer Center Baltimore Maryland 21201
Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center (SKCCC) Baltimore Maryland 21231
DFCI, Massachusetts General Hospital Boston Massachusetts 02114
Karmanos Cancer Institute, Children's Hospital of Michigan Detroit Michigan 48201
Washington University, Barnes Jewish Hospital St Louis Missouri 63110
Oregon Health & Science University Portland Oregon 97239-3098
Fox Chase, Temple University Philadelphia Pennsylvania 19111-2442
Medical University of South Carolina Charleston South Carolina 29425
Vanderbilt University Medical Center Nashville Tennessee 37232-8210
Baylor University Medical Center Dallas Texas 75246
Texas Transplant Institute San Antonio Texas 78229
Fred Hutchinson Cancer Research Center Seattle Washington 98109-1024

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00849147, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 3, 2023 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00849147 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →